CD4 and tuberculosis: “Resisters” were found to generate a non-IFN-γ-centric, Mtb-specific, CD4+ T-cell-mediated immune response to TB exposure, marked by high levels of up-regulated CD40L/CD154 in a clinical cohort study (Lu et al., 2019).